Astrana Health (ASTH) EBIT Margin: 2009-2024
Historic EBIT Margin for Astrana Health (ASTH) over the last 16 years, with FY2024 value amounting to 4.39%.
- Astrana Health's EBIT Margin fell 39300.0% to 2.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.1%, marking a year-over-year decrease of 28200.0%. This contributed to the annual value of 4.39% for FY2024, which is 17100.0% down from last year.
- Latest data reveals that Astrana Health reported EBIT Margin of 4.39% as of FY2024, which was down 17100.0% from 6.1% recorded in FY2023.
- Astrana Health's EBIT Margin's 5-year high stood at 12.69% during FY2021, with a 5-year trough of 4.39% in FY2024.
- Moreover, its 5-year median value for EBIT Margin was 9.11% (2022), whereas its average is 8.8%.
- Per our database at Business Quant, Astrana Health's EBIT Margin skyrocketed by 59300bps in 2020 and then plummeted by -35700bps in 2022.
- Over the past 5 years, Astrana Health's EBIT Margin (Annual) stood at 11.71% in 2020, then grew by 8bps to 12.69% in 2021, then decreased by -28bps to 9.11% in 2022, then crashed by -33bps to 6.1% in 2023, then fell by -28bps to 4.39% in 2024.
- Its EBIT Margin stands at 4.39% for FY2024, versus 6.1% for FY2023 and 9.11% for FY2022.